08/13/2025
4:47 PM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SCHEDULE 13G | |
08/11/2025
7:02 AM | Esperion Therapeutics (Filer)
| Form 8-K/A | |
08/05/2025
6:18 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
4:09 PM | Esperion Therapeutics (Subject)
Looker Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2025
2:39 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2025
7:18 AM | Esperion Therapeutics (Issuer)
THOMPSON JOHN CRAIG (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/02/2025
7:21 AM | Esperion Therapeutics (Issuer)
THOMPSON JOHN CRAIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
7:14 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
5:44 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
5:44 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
5:45 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ESPR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/17/2025
2:34 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2025
2:16 PM | Esperion Therapeutics (Subject)
Looker Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2025
8:01 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
6:25 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
11:15 PM | Esperion Therapeutics (Filer)
| Form EFFECT | |
04/17/2025
3:20 PM | Esperion Therapeutics (Filer)
| Form DEFA14A | |
04/17/2025
3:24 PM | Esperion Therapeutics (Filer)
| Form ARS | |
04/17/2025
2:08 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2025
2:14 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
1:15 PM | Esperion Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SCHEDULE 13G/A | |
04/04/2025
3:15 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
2:20 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
2:23 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
2:11 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
4:15 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:16 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:16 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:17 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
10:12 AM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/07/2025
8:04 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
6:26 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
2:34 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:26 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
1:37 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
3:37 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:38 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
2:30 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
2:17 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
7:40 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Trump’s “Smart Dollar” could rewrite the rules (Ad) MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar
Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now. Get the three steps to take this month to put yourself on the right side of this $30 trillion money |
12/18/2024
3:13 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:14 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
6:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
2:46 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
2:21 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
2:22 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2024
5:43 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:42 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:22 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:33 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:09 AM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G | |
10/18/2024
3:08 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
3:34 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/17/2024
2:25 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:11 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
2:20 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
2:28 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free ESPR Stock Alerts